Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 27, Issue 40, Pages 6775-6793
Publisher
Baishideng Publishing Group Inc.
Online
2021-10-27
DOI
10.3748/wjg.v27.i40.6775
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
- (2020) Christoph Fraune et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor Immunology and Tumor Evolution: Intertwined Histories
- (2020) Jérôme Galon et al. IMMUNITY
- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- Immunotherapy for pancreatic cancer: A 2020 update
- (2020) Dimitrios Schizas et al. CANCER TREATMENT REVIEWS
- The Immune Microenvironment in Pancreatic Cancer
- (2020) Magdalena Huber et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
- (2020) Mark H O'Hara et al. LANCET ONCOLOGY
- Neutrophil Degranulation, Plasticity, and Cancer Metastasis
- (2019) Faustino Mollinedo TRENDS IN IMMUNOLOGY
- A randomized Phase 2b study of GVAX pancreas and CRS-207 compared to chemotherapy in previously-treated metastatic pancreatic adenocarcinoma patients (ECLIPSE Study)
- (2019) Dung T. Le et al. CLINICAL CANCER RESEARCH
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
- (2019) Seon Ah Lim et al. Frontiers in Immunology
- Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- (2019) Eileen M. O’Reilly et al. JAMA Oncology
- Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
- (2019) Rosalinda Trovato et al. Journal for ImmunoTherapy of Cancer
- Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
- (2019) Sireesha Upadhrasta et al. Journal of Clinical Medicine
- Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion
- (2019) E M O’Reilly et al. ANNALS OF ONCOLOGY
- Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
- (2019) Anita Thyagarajan et al. Cancers
- Activated pancreatic stellate cells inhibit NK cell function in the human pancreatic cancer microenvironment
- (2018) Qiang Huang et al. Cellular & Molecular Immunology
- Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
- (2018) Zishuo I. Hu et al. CLINICAL CANCER RESEARCH
- Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
- (2018) Mohamed E. Salem et al. MOLECULAR CANCER RESEARCH
- Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine
- (2018) Andrew J Aguirre et al. Cancer Discovery
- New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
- (2018) Juan-Luis Blazquez et al. Frontiers in Immunology
- Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers
- (2018) V. Chung et al. Clinical & Translational Oncology
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape
- (2017) Leisha A. Emens et al. EUROPEAN JOURNAL OF CANCER
- Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
- (2017) Glen J. Weiss et al. INVESTIGATIONAL NEW DRUGS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
- (2017) Kaichao Feng et al. Protein & Cell
- Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
- (2016) David Balli et al. CLINICAL CANCER RESEARCH
- The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases
- (2016) Kota Arima et al. International Journal of Clinical Oncology
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
- (2016) K. E. Pauken et al. SCIENCE
- The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer
- (2016) Hai Hu et al. TUMOR BIOLOGY
- Epidemiology of pancreatic cancer
- (2016) Milena Ilic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict lymph node metastasis in patients with pancreatic ductal adenocarcinoma (PDAC)
- (2016) Lianyuan Tao et al. Oncotarget
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
- (2015) C. J. Whatcott et al. CLINICAL CANCER RESEARCH
- Stromal biology and therapy in pancreatic cancer: a changing paradigm
- (2015) Albrecht Neesse et al. GUT
- Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival.
- (2015) Chan Whiting et al. JOURNAL OF CLINICAL ONCOLOGY
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
- (2015) Laura Pinton et al. Oncotarget
- Pancreatic cancer: Update on immunotherapies and algenpantucel-L
- (2015) Kinsey A. McCormick et al. Human Vaccines & Immunotherapeutics
- Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
- (2015) Stalin Chellappa et al. OncoImmunology
- A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
- (2014) M. Aglietta et al. ANNALS OF ONCOLOGY
- Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction
- (2014) Yun-Peng Peng et al. BMC CANCER
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- IRF4 at the crossroads of effector T-cell fate decision
- (2014) Magdalena Huber et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Carcinoembryonic Antigen-Specific but Not Antiviral CD4+ T Cell Immunity Is Impaired in Pancreatic Carcinoma Patients
- (2014) E. Tassi et al. JOURNAL OF IMMUNOLOGY
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration
- (2014) Jennifer Watt et al. OncoImmunology
- Exomics and immunogenics
- (2014) Stéphane Champiat et al. OncoImmunology
- Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
- (2013) Y Ino et al. BRITISH JOURNAL OF CANCER
- Tumour–stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies
- (2013) V. Heinemann et al. CANCER TREATMENT REVIEWS
- Inflammatory networks and immune surveillance of pancreatic carcinoma
- (2013) Robert H Vonderheide et al. CURRENT OPINION IN IMMUNOLOGY
- PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis
- (2013) Bernd H. Zinselmeyer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer
- (2013) Dung T. Le et al. JOURNAL OF IMMUNOTHERAPY
- Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer
- (2013) Shingo Asahara et al. Journal of Translational Medicine
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and Therapy
- (2013) Mark J. Dobrzanski Frontiers in Oncology
- Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) T. Seufferlein et al. ANNALS OF ONCOLOGY
- Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients
- (2012) Hidekazu Kameshima et al. CANCER SCIENCE
- The Pancreas Cancer Microenvironment
- (2012) C. Feig et al. CLINICAL CANCER RESEARCH
- Effect of Pemetrexed on Innate Immune Killer Cells and Adaptive Immune T Cells in Subjects With Adenocarcinoma of the Pancreas
- (2012) Marcherie Davis et al. JOURNAL OF IMMUNOTHERAPY
- Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation
- (2012) N. Patsoukis et al. Science Signaling
- Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome
- (2012) BARBARA VIZIO et al. Experimental and Therapeutic Medicine
- A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
- (2011) Lutz Eric et al. ANNALS OF SURGERY
- Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent
- (2011) Skye C. Mayo et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
- (2011) Lucia De Monte et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cellular Vaccine Approaches
- (2010) Dung T. Le et al. CANCER JOURNAL
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- (2010) Richard E. Royal et al. JOURNAL OF IMMUNOTHERAPY
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized dendritic cell-based tumor immunotherapy
- (2009) Nona Janikashvili et al. Immunotherapy
- Immunosurveillance of pancreatic adenocarcinoma: Insights from genetically engineered mouse models of cancer
- (2008) Carolyn E. Clark et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation